LHV finantsportaal

Foorum Investeerimine

Börsipäev 11. juuni

Kommentaari jätmiseks loo konto või logi sisse

  • Lühiajaliselt ülemüüdud sentiment aktsiaturgudel lõi hea pinnase Kreekaga seotud spekulatsioonide toel suuremaks ülespoole liikumiseks, kui Euroopas sulgus Stoxx 600 indeks 1,8% kõrgemal ja Ühendriikides pani S&P 500 päevale punkti 1,2% tõusuga. Seejuures ei morjendanud investoreid isegi võlakirjade tulususte edasine tõus, mis võib näidata, et sisimas kõrgemate intressimäärade pärast väga ei muretsetagi, kui majandusstabiilsust ähvardavaid riskifaktoreid valemist eemaldada.

    Brüsselis kohtunud Saksamaa, Prantsusmaa ja Kreeka juhid ei avanud oma vestluse täpsemaid detaile, nentides vaid kokkuvõttes, et üksmeelselt nõustuti vajaduses intensiivistada erimeelsuste ületamiseks läbirääkimiste protsessi. Elevust tekitas Bloombergi uudis, milles väideti kahele Saksamaa valitsuse ametnikule tuginedes, et Kreekale finantsabi jagamiseks võib Saksamaa rahulduda ka riigi selge pühendumusega viia reformikava ellu järkjärgult, mis tõele vastates märgiks pehmemat seisukohta.

    Eraldiseisvalt langetas Standard & Poor’s pärast USA börside sulgumist Kreeka krediidireitingu CCC+ pealt CCC peale ning säilitas negatiivse väljavaate. Peamise põhjusena toodi välja IMFi ees võlakohustuse edasilükkamist, mis reitinguagentuuri sõnul näitab seda, et riik hindab võla teenindamise kõrval tähtsamaks pensionite maksmist ja muid siseriiklikke kulutusi.

    USA valitsuse eelarve puudujääk osutus mais oodatust väiksemaks, ulatudes -97 miljardi dollari asemel -82 miljardi dollarini. Ehkki läinud aasta oktoobris alanud fiskaalaastal on USA valitsuse kulud siiani kasvanud aasta varasema perioodiga võrreldes 6%, on maksutulude 9% kasv aidanud vähendada viimase 12 kuu puudujääki 412 miljardi dollarini, mis on märksa parem aastatagusest 491 miljardist dollarist ja madalaim 12 kuu näitaja alates 2008.a augustist.


    Tänase börsipäeva tähtsamatest majandusuudistest väärivad suurimat tähelepanu USA maikuu jaemüük ning möödunud nädala esmased töötu abiraha taotlused.

    09.45 Prantsusmaa inflatsioon (mai lõplik)
    10.30 Rootsi inflatsioon (mai)
    15.30 USA jaemüük (mai)
    15.30 USA esmased töötu abiraha taotlused
  • Hiina maikuu jaemüük kasvas YoY ootuspärased 10,1% ja tööstustoodangu kasv kiirenes 5,9% pealt 6,1% peale, mis oli mõnevõrra parem kui prognoositud 6,0%


    Uusi laenusid väljastati Hiinas 900,8 miljardit jüaani vs oodatud 850 miljardit ja 707,9 miljardit aprillis
  • Rootsi kroon on euro vastu täna 0,8% tugevnenud pärast maikuu inflatsiooni statistikat, mis näitas et 0,2% deflatsioon pöördus 0,1% inflatsiooniks, üllatades analüütikute -0,1% ootusega võrreldes

  • Keskmise maja hind Rootsis jätkas mais langust, tulles 2,396 miljoni Rootsi krooni pealt 2,375 miljonile.
  • USA maikuu jaemüük autosid ja kütust arvestamata oodatust parem

    US Retail Sales Advance (MoM) May: 1.20% (est 1.20%; rev prev 0.20%)
    US Retail Sales Ex-Auto and Gas (MoM) May: 0.70% (est 0.50%; prev 0.20%)
    US Initial Jobless Claims Jun-06: 279K (est 275K; rev prev 277K)
  • Gapping up
    In reaction to strong earnings/guidance:
    BOX +11.4%, MW +7.6%, KKD +6.2%, DDC +3.4%

    M&A news: ISSI +3.6% (Integrated Silicon amends its merger agreement with Uphill Investment, increasing the acquisition price to $21/share from $20/share for ISSI shares), HE +0.6% (shareholders approve merger with NextEra Energy (NEE))

    Other news: ATOS +10.7% (announces the U.S. Patent and Trademark Office has issued a new patent, Serial No. 9,052,318, to Atossa for Breast Cancer Detection using Absorbent Paper), ISIS +8% (reports Data from ISIS-SMN Rx Phase 2 Study in Infants with Spinal Muscular Atroph), CLLS +3.4% (announced publication of a study in Molecular Therapy describing the development of the next generation of engineered CAR T-cells compatible with allogeneic adoptive transfer immunotherapy), DMND +2.6% (favorable commentary on Wednesday's Mad Money), RBS +2.1% (UK confirms plans to begin sales of government's RBS stake - will begin in the coming months), AMGN +1.5% (FDA Advisory Committee votes 15-0 in favor of recommending approval of Repatha (evolocumab) for lowering LDL-C in patients with HoFH), AGIO +1.5% (confirms the FDA has granted it orphan drug designation for AG-120 for the treatment of patients with acute myelogenous leukemia), NKE +1.1% (NIKE to become exclusive oncourt provider for NBA, WNBA, NBA D-league), LNG +0.9% (announced 2 significant LNG projects; may add up to 19 mtpa in new liquefaction capacity by 2025), ISBC +0.7% (announced its second share repurchase program; may repurchase an additional 10% of its common stock, or ~34 mln shares)

    Analyst comments: PTBI +13.2% (initiated with a Buy at ROTH Capital; tgt $16), AGEN +3.6% (initiated with an Outperform at Oppenheimer), NPTN +2.4% (upgraded to Outperform from Mkt Perform at Raymond James), RAD +2.2% (resumed with a Outperform at Credit Suisse), ERF +2.2% (upgraded to Buy from Hold at TD Securities), HZNP +1.9% (initiated with a Overweight at Morgan Stanley), TOL +1.7% (upgraded to Outperform from Neutral at Credit Suisse), FDX +1.2% (added to Focus List at Citigroup; target raised to $206 from $198 at Credit Suisse ), AWAY +0.8% (initiated with an Overweight at a boutique firm), HOS +0.7% (initiated with an Overweight at Barclays), NFLX +0.7% (target raised to $746 at Topeka Capital Markets), HLT +0.7% (initiated with a Buy at Brean Capital)

    Gapping down
    In reaction to disappointing earnings/guidance: BV -5.4%, GWR -0.6%, DEST -0.6%

    M&A news: SYT -1% (cont uncertaintly surrounding merger with MON)

    Select metals/mining stocks trading lower: MT -1.7%, AUY -1.5%, FCX -1%, SLV -1%, HMY -0.7%, GG -0.5%

    Other news: FOLD -7.5% ( announces a $150 stock offering), COMM -5.9% ( announces sale of 20 mln shares of common stock by Carlyle Group), GLP -5.5% ( announces an offering of 3 mln common units), DRNA -5.5% (responds to complaint file by Alnylam Pharmaceuticals (ALNY) in US Superior Court; 'believes the complaint is meritless'), SALT -4.4% (prices offering of 133,000,000 shares of common stock at $1.50 per share), BBG -3.8% (announces "at-the-market" equity offering; confirms increase to 2015 capex budget; establishes initial 2016 production growth range), LULU -3.3% (discloses filing for sale of up to 20,109,131 shares by founder Dennis J. Wilson; if entire amount sold, it would represent Wilson's entire stake), FRSH -3.1% (announced secondary common stock offering of 2 mln shares by selling sharholder), CYBR -2.6% (prices offering of 4,900,000 ordinary shares at a price of $61.00 per share sold by co and selling shareholders), TUBE -2.5% (prices follow-on offering of 5,263,246 shares of common stock at a price to the public of $15.75 sold by co and selling shareholders), WNC -1.9% (amended credit agreement regarding its $150 million asset-based revolving credit facility), BAS -1.8% (filed for $1 bln mixed securities shelf offering), PFPT -1.5% (announced an offering of $150 mln in convertible senior notes due 2020), IEX -1.3% (acquired specialty products valve firm, Alfa Valvole, for €102 million; with earnings accretion expected in the first full year after closing), NLSN -1% (announces a secondary offering of ~8.95 mln shares of common stock by affiliates of the Blackstone Group and The Carlyle Group )

    Analyst comments: CL -1.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley), HOG -0.9% (downgraded to Neutral from Outperform at Wedbush), RIG -0.7% (initiated with an Underweight at Barclays), CHK -0.5% (downgraded to Perform from Outperform at Oppenheimer)

    Allikas:Briefing.com

Teemade nimekirja